Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
11 studies found for:    Open Studies | "Diabetes Insipidus"
Show Display Options
Rank Status Study
1 Recruiting Metformin and Congenital Nephrogenic Diabetes Insipidus
Condition: Diabetes Insipidus
Intervention: Drug: Metformin
2 Recruiting Use of Copeptin in Diabetes Insipidus
Conditions: Diabetes Insipidus (Central and Nephrogen);   Primary Polydipsia
Interventions: Other: Water deprivation test;   Other: Water deprivationtest;   Other: Hypertonic saline infusion
3 Recruiting Shared Health Appointments and Reciprocal Enhanced Support
Condition: Diabetes Insipidus
Intervention:
4 Recruiting AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock
Condition: Traumatic Shock
Intervention: Drug: Vasopressin
5 Not yet recruiting Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus: A Randomized Controlled Trial
Condition: Bipolar Disorder
Interventions: Drug: Atorvastatin;   Other: placebo
6 Recruiting Tracking Neurodegeneration in Early Wolfram Syndrome
Conditions: Type 1 Diabetes;   Diabetes Insipidus;   Diabetes Mellitus;   Wolfram Syndrome
Intervention:
7 Recruiting Wolfram Syndrome International Registry and Clinical Study
Conditions: Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Deafness;   Diabetes Insipidus;   Ataxia
Intervention:
8 Recruiting Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome
Conditions: Healthy;   Polyuria-polydipsia Syndrome
Intervention:
9 Not yet recruiting Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy
Conditions: Diabetes Mellitus;   Iron Metabolism Disorders;   Gastroduodenal Ulcer;   Optic Atrophy;   Sensorineural Hearing Loss;   Platelet Dysfunction
Interventions: Drug: Deferiprone;   Drug: Acetylcysteine;   Drug: Sitagliptin and Metformin
10 Recruiting A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome
Conditions: Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Ataxia
Intervention: Drug: dantrolene sodium
11 Recruiting
Has Results
Study of the Effect of Intradialytic Vasopressin on Chronic Hypertension in Patients With End Stage Renal Disease
Conditions: Hypertension;   End Stage Renal Disease
Interventions: Drug: Vasopressin - Very Low Dose;   Drug: Vasopressin - Low Dose;   Drug: Placebo Comparator

Study has passed its completion date and status has not been verified in more than two years.